PIIINasdaqServices-Health ServicesFiscal year ends December 31Also trades as PIIIW
P3 Health Partners Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$3.81−0.33 (-7.97%)
Close on Oct 19, 2026
- Market cap
- $12.81M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$4.84 (−55.95%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
P3 Health Partners Inc. grew revenue 2.8% to $1.50B over the twelve months to Jun 30, 2026.
Revenue
$1.50B
+2.8% vs. a year earlier
Operating income
-$148.63M
TTM Q2 2026
EPS, diluted
-$33.00
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $12.81M
- P/E ratio
- –
- Price to sales
- 0.01
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $1.50B
- Net income
- -$98.44M
- EPS, diluted
- -$33.00
- Diluted shares
- 3M
Eight years at a glance
Fiscal years 2018 to 2025 and trailing twelve months, USD
Revenue
$1.50B+2.8% YoY
Operating income
-$148.63M
Net income
-$98.44M
EPS, diluted
-$33.00
Free cash flow
–
Reported periodTrailing twelve months